User:Jeremy S. Myers

From OpenWetWare
Revision as of 08:20, 14 August 2008 by Jeremy S. Myers (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Contact Info

(an artistic interpretation)
  • Jeremy S. Myers, Ph.D.
  • AstraZeneca Fellow
  • Advanced Targeted Proteomics Team Leader
  • Vanderbilt University School of Medicine
  • Mass Spectrometry Research Center
  • Nashville, TN, U.S.A.
  • jeremy.myers@vanderbilt.edu

for more information visit: http://www.advancedtargetedproteomics.com

Education

  • 2003-2007 Postdoctoral Fellow
  • 2003 Ph.D., Louisiana State University
  • 1999 B.S., Bucknell University

Research interests

  1. Targeted Mass Spectrometry-based Proteomics
  2. Targeted Therapeutics

Publications (since 2007)

  1. Myers JS, Zhao R, Xu X, Ham AJ, Cortez D. Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res. 2007 Jul 15;67(14):6685-90. PMID: 17638878

Useful links

Selected Protocols